You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Type 2 Medications Articles
Popular Type 2 Medications Articles
Highly Recommended Type 2 Medications Articles
Send a link to this page to your friends and colleagues.
Data presented at the October 2006 Annual Scientific Meeting of NAASO, The Obesity Society, found that 60 milligrams of orlistat (Xenical), in conjunction with a reduced-calorie diet, provided significantly greater reductions in LDL cholesterol and weight when compared to treatment with a placebo and a reduced-calorie diet.
The results were based on two multicenter, double-blind, randomized, placebo-controlled clinical trials of 576 patients that were conducted over a two-year period. Study results found that approximately 38 percent of orlistat-treated participants had a favorable shift in their LDL cholesterol level compared to 11 percent in the placebo group.
Additional results showed that during the first year of the study, 45 percent more participants treated with orlistat plus a reduced-calorie diet lost at least five percent of their weight, compared to 29 percent treated with a placebo plus diet.
Orlistat works by preventing the absorption of approximately 25 percent of fat consumed. As a result of undigested fat passing through the body, users may experience gastrointestinal treatment effects.
Categories: Type 2 Medications
Feb 1, 2007
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.